2 天
The Brighterside of News on MSNRevolutionary new drug is a major breakthrough in diabetes careDiabetes affects millions worldwide, often triggering complications such as insulin resistance and fatty liver disease. To ...
10 小时on MSNOpinion
HB 2048 allows hospitals to receive massive discounts on prescription drugs without any requirement to pass along to patients ...
Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...
Amy Schumer endorses the new weight loss drug Mounjaro, praising its effectiveness after an adverse experience with Wegovy.
Pioglitazone/metformin FDC with dapagliflozin may provide effective and safe management for Type 2 diabetes. Read more!
Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...
This simple, cost-effective tool has the potential to revolutionize type 2 diabetes care, helping millions of people ...
Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...
A new study has revealed that semaglutide, a widely used diabetes and weight loss drug, sold under the brand name Ozempic, ...
ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.
5 天
The Print on MSNFat-busting drug Mounjaro launched in India. Here’s how much it will costUS pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...
4 天
HealthShots on MSNEli Lilly launches anti-obesity drug in India: Know all about Mounjaro for weight LossPharma giant Eli Lilly has launched a new anti-obesity and diabetes drug in India called Mounjaro. But should you take ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果